ImmunityBio Stock Surges for Tenth Straight Day on Revenue Jump
ImmunityBio shares rose 30.79% Thursday, marking a 10-day rally after reporting a 700% increase in preliminary 2025 revenue for its drug Anktiva.
Topic
Latest reporting and analysis tagged with stock market.
ImmunityBio shares rose 30.79% Thursday, marking a 10-day rally after reporting a 700% increase in preliminary 2025 revenue for its drug Anktiva.
Figure Technology Solutions stock surged to a new all-time high on Thursday following Piper Sandler's price target increase and the launch of its On-Chain Public Equity Network.
Erasca Inc. shares surged 15% to a three-year high after four investment firms issued bullish ratings and raised price targets, citing positive clinical trial data.
Fluence Energy's stock rose sharply Thursday, hitting a two-year high ahead of its Q1 2026 earnings release and a new supply agreement for an Arizona energy project.
Penumbra Inc. stock reached a record high after Boston Scientific announced a $14.5 billion acquisition agreement. The deal is expected to close in 2026.
Entegris Inc. shares rose sharply Thursday, hitting a 52-week high after UBS upgraded its price target and the company announced a quarterly dividend.
CompoSecure Inc. stock gained for a third day after announcing a $2.5 billion refinancing to cut debt and plans to rebrand as GPGI Inc. following a merger.
U.S. stocks turned lower Friday after President Trump expressed reluctance to name Kevin Hassett as the next Federal Reserve chair, fueling market uncertainty. The Nasdaq and S&P 500 slipped, while bank earnings provided some support.
Warren Buffett's long-term investment approach, detailed in his shareholder letters, highlights the importance of maintaining conviction in stock picks despite occasional underperformance and market volatility.